Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-11-27 Simpson Curran SVP, Technical Operations Sale −2,000 $29.31 $59K 39,500
2017-11-27 Simpson Curran SVP, Technical Operations Exercise or conversion · Stock Option (Right to Buy) −2,000 8,000
2017-11-20 Mills Kenneth T. President and CEO Exercise or conversion +30,000 $0.85 $26K 128,530
2017-11-20 Mills Kenneth T. President and CEO Sale −10,000 $27.71 $277K 118,530
2017-11-20 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −30,000 529,670
2017-11-15 Vasista Vittal Chief Financial Officer Sale −5,000 $25.30 $127K 87,283
2017-10-20 Mills Kenneth T. President and CEO Sale −9,800 $32.61 $320K 98,730
2017-10-20 Mills Kenneth T. President and CEO Sale −200 $33.03 $7K 98,530
2017-10-16 Vasista Vittal Chief Financial Officer Sale −5,000 $33.25 $166K 92,283
2017-10-11 HAYDEN DONALD J JR Director Exercise or conversion +20,000 $0.85 $17K 20,000
2017-10-11 HAYDEN DONALD J JR Director Sale −20,000 $34.95 $699K 0
2017-10-11 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −20,000 234,100
2017-09-27 HAYDEN DONALD J JR Director Exercise or conversion +20,000 $0.85 $17K 20,000
2017-09-27 HAYDEN DONALD J JR Director Sale −20,000 $32.45 $649K 0
2017-09-27 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −20,000 254,100
2017-09-20 Mills Kenneth T. President and CEO Sale −9,900 $29.32 $290K 108,630
2017-09-20 Mills Kenneth T. President and CEO Sale −100 $30.05 $3K 108,530
2017-09-18 HAYDEN DONALD J JR Director Exercise or conversion +20,000 $0.85 $17K 20,000
2017-09-18 HAYDEN DONALD J JR Director Sale −20,000 $29.95 $599K 0
2017-09-18 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −20,000 274,100

Page 45 of 56 · 1,104 trades